Drug
Hrs 7172 AG Shr 1316
Hrs 7172 AG Shr 1316: highest development phase Phase 1/2, developed by Jiangsu Hengrui Medicine. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1/2
- Developer
- Jiangsu Hengrui Medicine
Trials
| Drug | Phase | Indication |
|---|---|---|
| HRS-7172 + AG + SHR-1316 NCT07806058 | Phase 1/2 | Pancreatic Cancer |
Latest
No recent events.
Follow Hrs 7172 AG Shr 1316 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.